Therapeutic Advances in Respiratory Disease

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montuschi, P.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Therapeutic Advances in Respiratory Disease, Vol. 1, No. 1, 5-23 (2007)
DOI: 10.1177/1753465807082373

Reviews

Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications

Paolo Montuschi

Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy, pmontuschi{at}rm.unicatt.it

Analysis of exhaled breath condensate (EBC) is a noninvasive method for studying the composition of airway lining fluid and has the potential for assessing lung inflammation. EBC is mainly formed by water vapor, but also contains aerosol particles in which several biomolecules including leukotrienes, 8-isoprostane, prostaglandins, hydrogen peroxide, nitric oxide-derived products, and hydrogen ions, have been detected in healthy subjects. Inflammatory mediators in EBC are detected in healthy subjects and some of them are elevated in patients with different lung diseases. Analysis of EBC is completely noninvasive, is particularly suitable for longitudinal studies, and is potentially useful for assessing the response to pharmacological therapy. Identification of selective profiles of biomarkers of lung diseases might also have a diagnostic value. However, EBC analysis currently has important limitations. The lack of standardized procedures for EBC analysis and validation of some analytical techniques makes it difficult comparison of results from different laboratories. Analysis of EBC is currently more useful for relative measures than for quantitative assessment of inflammatory mediators. Reference analytical techniques are required to provide definitive evidence for the presence of some inflammatory mediators in EBC and for their accurate quantitative assessment in this biological fluid. Several methodological issues need to be addressed before EBC analysis can be considered for clinical applications. However, further research in this area is warranted due to the relative lack of noninvasive methods for assessing lung inflammation.

Key Words: exhaled breath condensate • airway inflammation • non-invasive assessment • therapeutic monitoring • asthma • chronic obstructive pulmonary disease • eicosanoids

References

  • Adelroth, E. (1998) How to measure airway inflammation: bronchoalveolar lavage and airway biopsies. Can Respir J 5: 18A—21A.[Medline] [Order article via Infotrieve]
  • Anonymous (1999) Recommendations for standardised procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children — 1999. Official statement of the American Thoracic Society 1999. Am J Respir Crit Care Med 160: 2104—2117.[Free Full Text]
  • Anonymous (2005). ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 171: 912—930.[Free Full Text]
  • Antczak, A. et al. (1997) Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 10: 1235—1241.[Abstract]
  • Antczak, A. et al. (2001) Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 166: 301—306.[CrossRef]
  • Balint, B. et al. (2001) Increased nitrotyrosine
  • in exhaled breath condensate in cystic fibrosis. Eur Respir J 17: 1201—1207.
  • Baraldi, E. et al. (2003a) Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 58: 505—509.[Abstract/Free Full Text]
  • Baraldi, E. et al. (2003b) Increased exhaled 8-isoprostane in childhood asthma. Chest 124: 25—31.[CrossRef][Medline] [Order article via Infotrieve]
  • Baraldi, E. et al. (2006) 3-Nitrotyrosine, a marker of nitrosative stress, is increased in breath condensate of allergic asthmatic children. Allergy 61: 90—96.[Medline] [Order article via Infotrieve]
  • Barnes, P.J. (2000) Chronic obstructive pulmonary disease. N Engl J Med 343: 269—280.[Free Full Text]
  • Berlyne, G.S. et al.(2000) A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 106: 638—644.[CrossRef][Medline] [Order article via Infotrieve]
  • Biernacki, W.A. et al. (2003) Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 58: 294—298.[Abstract/Free Full Text]
  • Bodini, A. et al. (2006) Flunisolide decreases exhaled nitric oxide and nitrotyrosine levels in asthmatic children. Mediators Inflamm 4: 31919.
  • Brunetti, L. et al. (2006) Exhaled breath condensate pH measurement in children with asthma, allergic rhinitis and atopic dermatitis. Pediatr Allergy Immunol 17: 422—427.[CrossRef][Medline] [Order article via Infotrieve]
  • Cap, P. et al. (2004) Gas-chromatography mass spectrometry analysis of exhaled leukotrienes in asthmatic patients. Thorax 59: 465—470.[Abstract/Free Full Text]
  • Carpagnano, G.E. et al. (2003a) 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124: 1386—1392.[CrossRef][Medline] [Order article via Infotrieve]
  • Carpagnano, G.E. et al. (2003b) Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 167: 1109—1112.[Abstract/Free Full Text]
  • Carpagnano, G.E. et al. (2005) 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. Am J Respir Crit Care Med 172: 738—744.[Abstract/Free Full Text]
  • Carpenter, C.T. et al. (1998) Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury and ARDS. Chest 114: 1653—1659.[CrossRef][Medline] [Order article via Infotrieve]
  • Carraro, S. et al. (2005) Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol 115: 764—770.[CrossRef][Medline] [Order article via Infotrieve]
  • Celio, S. et al. (2006) Free 3-nitrotyrosine in exhaled breath condensates of children fails as a marker for oxidative stress in stable cystic fibrosis and asthma. Nitric Oxide 15: 226—232.[CrossRef][Medline] [Order article via Infotrieve]
  • Cepelak, I. et al. (2007) Exhaled breath condensate: a new method for lung disease diagnosis. Clin Chem Lab Med (in press).
  • Corradi, M. et al. (2001) Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med 163: 854—858.[Abstract/Free Full Text]
  • Corradi, M. et al. (2003a) Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbations. Am J Respir Crit Care Med 167: 395—399.[Abstract/Free Full Text]
  • Corradi, M. et al. (2003b) Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 1380—1386.[Abstract/Free Full Text]
  • Csoma, Z. et al. (2002) Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 166: 1345—1349.[Abstract/Free Full Text]
  • Cunningham, S. et al. (2000) Measurement of inflammatory markers in the breath condensate of children with asthma. Eur Respir J 15: 955—957.[Abstract]
  • De Benedetto, F. et al. (2001) Validation of a new technique to assess exhaled hydrogen peroxide: results from normals and COPD patients. Monaldi Arch Chest Dis 55: 185—188.
  • Decramer, M. et al. (2005) Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 365: 1552—1560.[CrossRef][Medline] [Order article via Infotrieve]
  • Dekhuijzen, R.P.N. et al. (1996) Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154: 813—816.[Abstract]
  • Dohlman, A.W. et al. (1993) Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Resp Dis 148: 955—960.[Medline] [Order article via Infotrieve]
  • Dupont, L.J. et al. (2006) The pH of exhaled breath condensate of patients with allograft rejection after lung transplantation. Am J Transplant 6: 1486—1492.[CrossRef][Medline] [Order article via Infotrieve]
  • Dwyer, T.M. (2001) Expired breath condensate (EBC) and the ultimate disposition of airway surface liquid (ASL). Am J Respir Crit Care Med 163: A406.
  • Effros, R.M. et al. (2002) Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med 165: 663—669.[Abstract/Free Full Text]
  • Effros, R.M. et al. (2003) A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med 168: 1500—1505.[Abstract/Free Full Text]
  • Effros, R.M. et al. (2005a) Utility of exhaled breath condensates in chronic obstructive pulmonary disease: a critical review. Curr Opin Pulm Med 11: 135—139.[CrossRef][Medline] [Order article via Infotrieve]
  • Effros, R.M. et al. (2005b) Exhaled breath condensate: formation and physicochemical properties. In Montuschi P (ed), New perspectives in monitoring lung inflammation: analysis of exhaled breath condensate. CRC Press: Boca Raton, Florida, pp. 31—52.
  • Emelyanov, A. et al. (2001) Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest 120: 1136—1139.[CrossRef][Medline] [Order article via Infotrieve]
  • Ferreira, I.M. et al. (2001) Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone. Am J Respir Crit Care Med 164: 1012—1015.[Abstract/Free Full Text]
  • Fixman, E.D. et al. (2007) Basic mechanisms of development of airway structural changes in asthma. Eur Respir J 29: 379—389.[Abstract/Free Full Text]
  • Gaber, F. et al. (2006) Saliva is one likely source of leukotriene B4 in exhaled breath condensate. Eur Respir J 28: 1229—1235.[Abstract/Free Full Text]
  • Gajdocsi, R. et al. (2003) The reproducibility and accuracy of the on-line hydrogen peroxide bioassay and the decreasing effect of storage on H2O2 concentration. Eur Respir J 22, Suppl. 45: 279s.
  • Ganas, K. et al. (2001) Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med 95: 649—654.[CrossRef][Medline] [Order article via Infotrieve]
  • Gaston, B. et al. (1998) Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 351: 1317—1319.[CrossRef][Medline] [Order article via Infotrieve]
  • Gessner, C. et al. (2004) Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. Lung Cancer 43: 215—222.[CrossRef][Medline] [Order article via Infotrieve]
  • Gianazza, E. et al. (2003) Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke. Am J Med 117: 51—54.
  • Goen, T. et al. (2005) Sensitive and accurate analyses of free 3-nitrotyrosine in exhaled breath condensate by LC-MS/MS. Chromatogr B Analyt Technol Biomed Life Sci 826: 261—266.
  • Hanazawa, T. et al. (2000) Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 162: 1273—1276.[Abstract/Free Full Text]
  • Horvath, I. et al. (1998) Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 158: 1042—1046.[Abstract/Free Full Text]
  • Horvath, I. et al. (2005) Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26: 523—548.[Abstract/Free Full Text]
  • Hunt, J. (2002) Exhaled breath condensate: an evolving tool for non-invasive evaluation of lung disease. J Allergy Clin Immunol 110: 28—34.[CrossRef][Medline] [Order article via Infotrieve]
  • Hunt, J. et al. (1995) Condensed expirate nitrite as a home marker for acute asthma. Lancet 346: 1235—1236.[Medline] [Order article via Infotrieve]
  • Hunt, J.F. et al. (2000) Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 161: 694—699.[Abstract/Free Full Text]
  • Huszar, E. et al. (2005) Comparative measurement of thromboxane A2 metabolites in exhaled breath condensate by different immunoassays. Inflamm Res 54: 350—355.[CrossRef][Medline] [Order article via Infotrieve]
  • Jackson, A.S. et al. (2007) Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med 175: 222—227.[Abstract/Free Full Text]
  • Jobsis, Q. et al. (2000) Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J 16: 95—100.[Abstract]
  • Jobsis, Q. et al. (1997) Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 10: 519—521.[Abstract]
  • Kasielski, M. and Nowak, D. (2001) Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 95: 448—456.[CrossRef][Medline] [Order article via Infotrieve]
  • Kharitonov, S.A. and Barnes, P.J. (2006) Exhaled biomarkers. Chest 130: 1541—1546.[CrossRef][Medline] [Order article via Infotrieve]
  • Kharitonov, S.A. and Barnes, P.J. (2001) Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 163: 1693—1722.[Free Full Text]
  • Kharitonov, S.A. et al. (2002) Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 57: 889—896.[Abstract/Free Full Text]
  • Kietzmann, D. et al. (1993) Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med 19: 78—81.[CrossRef][Medline] [Order article via Infotrieve]
  • Kostikas, K. et al. (2002) pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 165: 1364—1370.[Abstract/Free Full Text]
  • Kostikas, K. et al. (2003) Oxidative stress in expired breath condensate of patients with COPD. Chest 124: 1373—1380.[CrossRef][Medline] [Order article via Infotrieve]
  • Kostikas, K. et al. (2005) Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 127: 1553—1559.[CrossRef][Medline] [Order article via Infotrieve]
  • Kullmann, T. et al. (2006) Exhaled breath condensate pH standardised for CO2 partial pressure. Eur Respir J 29: 496—501.[Medline] [Order article via Infotrieve]
  • Kwiatkowska, S. et al. (2007) Elevated exhalation of hydrogen peroxide and circulating IL-18 in patients with pulmonary tuberculosis. Respir Med 101: 574—580.[CrossRef][Medline] [Order article via Infotrieve]
  • Larstad, M. et al. (2002) Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 766: 107—114.
  • Larstad, M. et al. (2003) Influence of sampling time on malondialdehyde levels and pH in exhaled breath condensate. Eur Respir J, Suppl 45: 38s.
  • Larstad, M. et al. (2005) Selective quantification of free 3-nitrotyrosine in exhaled breath condensate in asthma using gas chromatography/tandem mass spectrometry. Nitric Oxide 13: 134—144.[CrossRef][Medline] [Order article via Infotrieve]
  • Loukides, S. et al. (1998) Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am J Respir Crit Care Med 158: 991—994.[Abstract/Free Full Text]
  • Matsunaga, K. et al. (2006) Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients. J Allergy Clin Immunol 118: 84—90.[CrossRef][Medline] [Order article via Infotrieve]
  • McCafferty, J.B. et al. (2004) Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations. Thorax 59: 694—698.[Abstract/Free Full Text]
  • McKinney, E.T. et al. (2000) Plasma, urinary, and salivary 8-epi-prostaglandin F2{alpha} levels in normotensive and preeclamptic pregnancies. Am J Obstet Gynecol 183: 874—877.[CrossRef][Medline] [Order article via Infotrieve]
  • Mondino, C. et al. (2004) Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol 114: 761—767.[CrossRef][Medline] [Order article via Infotrieve]
  • Montuschi, P. (2002) Indirect monitoring of lung inflammation. Nat Rev Drug Discov 1: 238—242.[CrossRef][Medline] [Order article via Infotrieve]
  • Montuschi, P. (editor) (2005a) New perspectives in monitoring lung inflammation: analysis of exhaled breath condensate. CRC Press: Boca Raton, Florida.
  • Montuschi, P. et al. (2005b) Analysis of exhaled breath condensate: methodological issues. In Montuschi P (ed), New perspectives in monitoring lung inflammation: analysis of exhaled breath condensate. CRC Press: Boca Raton, Florida, pp. 11—30.
  • Montuschi, P. and Barnes, P.J. (2002a) Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 23: 232—237.[CrossRef][Medline] [Order article via Infotrieve]
  • Montuschi, P. and Barnes, P.J. (2002b) Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 109: 615—620.[CrossRef][Medline] [Order article via Infotrieve]
  • Montuschi, P. et al. (1999) Increased 8-isoprostane, a biomarker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 160: 216—220.[Abstract/Free Full Text]
  • Montuschi, P. et al. (2000) Exhaled 8-isoprostane as an in vivo biomarker of oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 162: 1175—1177.[Abstract/Free Full Text]
  • Montuschi, P. et al. (2002) Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide. Free Radic Biol Med 33: 1403—1408.[CrossRef][Medline] [Order article via Infotrieve]
  • Montuschi, P. et al. (2003a) Methodological aspects of exhaled prostanoid measurements. Eur Respir J, Suppl. 45: 18s.
  • Montuschi, P. et al. (2003b) Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. Inflamm Res 52: 502—507.[CrossRef][Medline] [Order article via Infotrieve]
  • Montuschi, P. et al. (2003c) Validation of leukotriene B4 measurements in exhaled breath condensate. Inflamm Res 52: 69—73.[CrossRef][Medline] [Order article via Infotrieve]
  • Montuschi, P. et al. (2003d) Exhaled leukotrienes and prostaglandins in COPD. Thorax 58: 585—588. Chest 127: 1553—1559.[CrossRef]
  • Montuschi, P. et al. (2004a) Ion trap liquid chromatography/tandem mass spectrometry analysis of leukotriene B4 in exhaled breath condensate. Rapid Commun Mass Spectrom 18: 2723—2729.[CrossRef][Medline] [Order article via Infotrieve]
  • Montuschi, P. et al. (2004b) Isoprostanes: markers and mediators of oxidative stress. FASEB J 18: 1791—1800.[Abstract/Free Full Text]
  • Montuschi, P. et al. (2005a) Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children. Respir Res 19: 6:119.
  • Montuschi, P. et al. (2005b) Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD. Thorax 60: 827—833.[Abstract/Free Full Text]
  • Montuschi, P. et al. (2006) Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. J Allergy Clin Immunol 118: 347—353.[CrossRef][Medline] [Order article via Infotrieve]
  • Montuschi, P. et al. (2007) Insights into oxidative stress: the isoprostanes. Curr Med Chem 14: 703—717.[CrossRef][Medline] [Order article via Infotrieve]
  • Morrow, J.D. et al. (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87: 9383—9387.[Abstract/Free Full Text]
  • Mutlu, G.M. et al. (2001) Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 164: 731—737.[Free Full Text]
  • Nicolau, N.C. et al. (2006) Exhaled breath condensate pH and childhood asthma: unselected birth cohort study. Am J Respir Crit Care Med 174: 254—259.[Abstract/Free Full Text]
  • Nowak, D. et al. (1999) Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 93: 389—396.[CrossRef][Medline] [Order article via Infotrieve]
  • O'Donnell, R. et al. (2006) Inflammatory cells in the airways in COPD. Thorax 61: 448—454.[Abstract/Free Full Text]
  • Paget-Brown, A.O. et al. (2006) Normative data for pH of exhaled breath condensate. Chest 129: 426—430.[CrossRef][Medline] [Order article via Infotrieve]
  • Prieto, L. et al. (2007) Differences in exhaled breath condensate pH measurements between samples obtained with two commercial devices. Respir Med (in press).
  • Profita, M. et al. (2006) Noninvasive methods for the detection of upper and lower airway inflammation in atopic children. J Allergy Clin Immunol 118: 1068—1074.[CrossRef][Medline] [Order article via Infotrieve]
  • Ratnawati, R. et al. (2006) Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide. Pediatr Pulmonol 41: 929—936.[CrossRef][Medline] [Order article via Infotrieve]
  • Rickmann, J. et al. (2001) Breath condensate reflects different compartments of respiratory tract depending on ventilation pattern. Am J Respir Crit Care Med 163: A407.
  • Robroeks, C.M. et al. (2006) Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis. Ann Allergy Asthma Immunol 96: 349—355.[Medline] [Order article via Infotrieve]
  • Rosias, P.P.R. et al. (2006) Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate. Eur Respir J 28: 1036—1041.[Abstract/Free Full Text]
  • Rozy, A. et al. (2006) Inflammatory markers in the exhaled breath condensate of patients with pulmonary sarcoidosis. J Physiol Pharmacol 57 (Suppl 4): 335—340.[Medline] [Order article via Infotrieve]
  • Rysz, J. et al. (2007) Increased hydrogen peroxide concentration in the exhaled breath condensate of stable COPD patients after nebulized N-acetylcysteine. Pulm Pharmacol Ther 20: 281—289.[CrossRef][Medline] [Order article via Infotrieve]
  • Sabroe, I. et al. (2007) Targeting the networks that underpin contiguous immunity in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175: 306—311.[Abstract/Free Full Text]
  • Sack, U. et al. (2006) Multiplex analysis of cytokines in exhaled breath condensate. Cytometry A 69: 169—172.[Medline] [Order article via Infotrieve]
  • Sandrini, A. et al. (2003a) Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest 124: 1334—1340.[CrossRef][Medline] [Order article via Infotrieve]
  • Sandrini, A. et al. (2003b) Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol 111: 313—320.[CrossRef][Medline] [Order article via Infotrieve]
  • Scheideler, L. et al. (1993) Detection of nonvolatile macromolecules in breath: a possible diagnostic tool? Am Rev Respir Dis 148: 778—784.[Medline] [Order article via Infotrieve]
  • Schleiss, M.B. et al. (2000) The concentration of hydrogen peroxidein exhaled air depends on expiratory floe rate. Eur Respir J 16: 1115—1118.[Abstract]
  • Shahid, S.K. et al. (2002) Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 165: 1290—1293.[Abstract/Free Full Text]
  • Shahid, S.K. et al. (2005) Exhaled 8-isoprostane in childhood asthma. Respir Res 6: 79.[Medline] [Order article via Infotrieve]
  • Shibata, A. et al. (2006) Increased leukotriene E4 in the exhaled breath condensate of children with mild asthma. Chest 130: 1718—1722.[CrossRef][Medline] [Order article via Infotrieve]
  • Shimizu, Y. et al. (2007) Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease. Respiration (in press).
  • Smith, A.D. et al. (2005) Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352: 2163—2173.[Abstract/Free Full Text]
  • Soyer, O.U. et al. (2006) Comparison of two methods for exhaled breath condensate collection. Allergy 61: 1016—1018.[CrossRef][Medline] [Order article via Infotrieve]
  • Svensson, S. et al. (2003) Sampling time is important for the collection of hydrogen peroxide in exhaled breath condensate (EBC). Eur Respir J, Suppl 45: 78s.
  • van Beurden, W.J. et al.(2003a) Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients. Respiration 70: 242—248.[CrossRef][Medline] [Order article via Infotrieve]
  • van Beurden, W.J. et al. (2003b) Markers of inflammation and oxidative stress during lower respiratory tract infections in COPD patients. Monaldi Arch Chest Dis 59: 273—280.[Medline] [Order article via Infotrieve]
  • Vass, G. et al. (2003) Comparison of nasal and oral inhalation during exhaled breath condensate collection. Am J Respir Crit Care Med 167: 850—855.[Abstract/Free Full Text]
  • Vaughan, J. et al. (2003) Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 22: 889—894.[Abstract/Free Full Text]
  • Vogelberg, C. et al. (2003) Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis. Pediatr Pulmonol 36: 348—352.[CrossRef][Medline] [Order article via Infotrieve]
  • Walsh, B.K. et al. (2006) Exhaled-breath condensate pH can be safely and continuously monitored in mechanically ventilated patients. Respir Care 51: 1125—1131.[Medline] [Order article via Infotrieve]
  • Wenzel, S.E. (2006) Asthma: defining of the persistent adult phenotypes. Lancet 368: 804—813.[CrossRef][Medline] [Order article via Infotrieve]
  • Zakrzewski, J.T. et al. (1987) Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease. Am Rev Respir Dis 136: 779—782.[Medline] [Order article via Infotrieve]
  • Zanconato, S. et al. (2004) Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 113: 257—263.[CrossRef][Medline] [Order article via Infotrieve]
  • Zappacosta, B. et al. (2001) A fast chemiluminescent method for H(2)O(2) measurement in exhaled breath condensate. Clin Chim Acta 310: 187—191.[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montuschi, P.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?